Thromboembolic complications in cancer

Joanna Stanisławiak; Janina Markowska

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2008
vol. 12

Send email

Copy url:

abstract:

Thromboembolic complications in cancer

Joanna Stanisławiak

,

Janina Markowska

Współczesna Onkologia (2008) vol. 12; 2 (56–60)

Online publish date: 2008/04/22

View full text Get citation

Thrombosis is a frequent complication of cancer. The many signs and symptoms of the prothrombotic state in cancer range from asymptomatic basic abnormal coagulation tests to massive clinical thromboembolism, when the patient may be gravely ill. Deep venous thrombosis (DVT) of the leg and pulmonary embolism are the most common clinical manifestations of thromboembolic disease in cancer patients. Procoagulants such as tissue factor (TF) are expressed by many tumours, although platelet turnover and activity are also increased. Damaged endothelium and blood flow abnormalities may also play a part in cancer. The mechanisms of tumour-associated hypercoagulability may help to identify more targeted strategies to prevent thromboembolic complications in cancer patients, in particular when surgical or chemical therapy is involved.

keywords:

Thromboembolic complications in cancer

Joanna Stanisławiak , Janina Markowska

cancer, hypercoagulability, iatrogenic thrombosis, prognostic factor

Joanna Stanisławiak

,

Janina Markowska